UZ Leuven and VIB-KU Leuven, in collaboration with Seattle-based Presage Biosciences, are announcing the first patient ...

Media Release COPENHAGEN, Denmark; March 31, 2025 TIVDAK® is the first and only antibody-drug conjugate (ADC) approved to treat recurrent or metastatic cervical cancer with disease progression on or ...

Mixx Technologies, Inc., a pioneer in next-generation optical interconnect solutions, today announced its Advanced 3DS Platform, an ultra-efficient connectivity fabric that is redefining AI and ...